BARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement
Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
---|---|
Level of Government: | Federal |
Category: |
|
Opps ID: | NBD00159088655340809 |
Posted Date: | Jun 29, 2020 |
Due Date: | Feb 3, 2023 |
Solicitation No: | BAA-20-100-SOL-0002 |
Source: | https://beta.sam.gov/opp/1eede... |
- Contract Opportunity Type: Solicitation (Updated)
- All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
- Updated Published Date: Jun 29, 2020 09:39 am EDT
- Original Published Date: Feb 03, 2020 02:46 pm EST
- Updated Date Offers Due: Feb 03, 2023 05:00 pm EST
- Original Date Offers Due: Feb 03, 2023 05:00 pm EST
- Inactive Policy: 15 days after date offers due
- Updated Inactive Date: Feb 18, 2023
- Original Inactive Date: Feb 18, 2023
-
Initiative:
- None
- Original Set Aside:
- Product Service Code: AN13 - R&D- MEDICAL: BIOMEDICAL (ADVANCED DEVELOPMENT)
- NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
-
Place of Performance:
Washington , DC 20201USA
6/29/2020 - Please see Special Instructions 009 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 009, BARDA is revising topics #4.1-D and #4.3 immediately, and extending the closing date to 2359 HRS ET on 31 October 2020 under its temporary AOI #4: COVID-19 as part of its EZ-BAA (BAA-20-100-SOL-0002).
6/4/2020 - Amendment 001 to the EZ-BAA is now included as an attachment. Amendment 001 revises Section C of the EZ-BAA.
Please also see Special Instructions 008 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 008, BARDA is revising topic #4.3 immediately, and closing topic #4.4 at 1700 HRS ET on 05 June 2020 under its temporary AOI #4: COVID-19 as part of its EZ-BAA (BAA-20-100-SOL-0002).
5/12/2020 - Please see Special Instructions 007 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 007, BARDA is closing topics #4.1-B and #4.1-C under its temporary AOI #4: COVID-19 as part of its EZ-BAA (BAA-20-100-SOL-0002).
4/27/2020 - Please see Special Instructions 006 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 006, BARDA is adding topic #4.1-D under its temporary AOI #4: COVID-19 as part of its EZ-BAA (BAA-20-100-SOL-0002).
4/2/2020 - Please see Special Instructions 005 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 005, BARDA is closing topic #4.1-A and revising topic #4.1-C under its temporary AOI #4: COVID-19 as part of its EZ-BAA (BAA-20-100-SOL-0002).
3/18/2020 - Please see Special Instructions 004 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 004, BARDA is closing topic #4.2 under its temporary AOI #4: COVID-19 as part of its EZ-BAA (BAA-20-100-SOL-0002).
3/9/2020 - Please see Special Instructions 003 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions, BARDA is adding several new topics under its temporary AOI #4: COVID-19 (renamed from 2019-nCoV) as part of its EZ-BAA (BAA-20-100-SOL-0002).
2/15/2020 - Please see Special Instructions 002 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions, BARDA is adding a new topic under its temporary AOI #4: 2019-nCoV as part of its EZ-BAA (BAA-20-100-SOL-0002).
2/3/2020 - Please see Special Instructions 001 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions, BARDA is temporarily suspending AOIs 1-3 as part of its EZ-BAA (BAA-20-100-SOL-0002), but is pleased to announce that it is now accepting abstract submissions for AOI #4: 2019-nCoV.
2/3/2020 - See attachment(s). This Easy Broad Agency Announcement (EZ-BAA) sets forth areas of interest (AOIs) for the Division of Research, Innovation, and Ventures (DRIVe) in the Office of Biomedical Advanced Research and Development Authority (BARDA), issued under paragraph 6.102(d)(2)(i) of the Federal Acquisition Regulation (FAR). Abstract submissions selected for award are considered to be the result of full and open competition and in full compliance with 41 U.S.C. ยง 3301.
- 200 Independence Avenue, SW
- Washington , DC 20201
- USA
- Troy Francis - Contracting Officer (Team Lead), DRIVe
- troy.francis@hhs.gov
- Matthew McCord - Chief of Partnering, DRIVe
- matthew.mccord@hhs.gov
- Jun 29, 2020 09:39 am EDTSolicitation (Updated)
- Jun 04, 2020 03:49 pm EDT Solicitation (Updated)
- May 12, 2020 05:48 pm EDT Solicitation (Updated)
- May 12, 2020 05:46 pm EDT Solicitation (Updated)
- May 12, 2020 05:42 pm EDT Solicitation (Inactive)
- Apr 27, 2020 08:21 am EDT Solicitation (Updated)
- Apr 27, 2020 08:09 am EDT Solicitation (Updated)
- Apr 10, 2020 04:31 pm EDT Solicitation (Updated)
- Apr 02, 2020 05:30 pm EDT Solicitation (Updated)
- Apr 02, 2020 04:32 pm EDT Solicitation (Updated)
- Mar 18, 2020 04:46 pm EDT Solicitation (Updated)
- Mar 09, 2020 09:23 pm EDT Solicitation (Updated)
- Feb 15, 2020 05:17 am EST Solicitation (Updated)
- Feb 14, 2020 06:53 pm EST Solicitation (Updated)
- Feb 13, 2020 07:35 pm EST Solicitation (Updated)
- Feb 13, 2020 07:29 pm EST Solicitation (Updated)
- Feb 03, 2020 03:52 pm EST Solicitation (Updated)
- Feb 03, 2020 03:49 pm EST Solicitation (Updated)
- Feb 03, 2020 03:48 pm EST Solicitation (Inactive)
- Feb 03, 2020 02:46 pm EST Solicitation (Original)
TRY FOR FREE
Not a USAOPPS Member Yet?
Get unlimited access to thousands of active local, state and federal government bids and awards in All 50 States.